HEMSLEY STEPHEN J 4
Research Summary
AI-generated summary
UnitedHealth CEO Stephen Hemsley Receives 61-Share Award
What Happened
- Stephen J. Hemsley, CEO and Director of UnitedHealth Group (UNH), was granted/received 61 shares on March 17, 2026. The shares were recorded at $0.00 per share (total value $0) because they represent dividend equivalents paid on vested deferred stock units and were immediately vested.
Key Details
- Transaction date: 2026-03-17; Filing date: 2026-03-19 (filing appears timely).
- Transaction type: Award/grant (code A); price reported $0.00; total reported value $0.
- Footnote F1: These 61 shares represent dividend equivalents on vested deferred stock units; the dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units.
- Footnotes F2/F3: The filing notes a separate, earlier contribution of 10,380 shares to the reporting person's trusts on Jan 29, 2026; the trust contribution was exempt from reporting under Rule 16a-13 and is referenced for ownership calculations.
- The filing does not show a cash purchase or sale—this is an award, not a market buy or sale.
Context
- Awards of dividend equivalents on deferred stock units are routine compensation-related events and do not necessarily signal the insider buying or selling stock in the open market.
- For retail investors, purchases are often given more weight than awards; this transaction primarily reflects compensation mechanics rather than a new cash investment by the CEO.